Spontaneously arising red cells with a McLeod-like phenotype in normal donors

David J Araten1, Katie J Sanders, Jeffrey Pu

  • 1Division of Hematology, Department of Medicine, NYU School of Medicine, New York, NY, United States. David.Araten@nyumc.org

Mutation Research
|November 14, 2009
PubMed

Insights

Researchers identified rare red blood cells with inactivating mutations in the XK gene. This method may help study aging, mutations, and cancer development.

Area of Science:

  • Genetics
  • Hematology
  • Cell Biology

Background:

  • Identifying spontaneous inactivating somatic mutations in human genes is challenging.
  • The XK gene, located on the X chromosome, is associated with McLeod syndrome when mutated.
  • X-linked genes offer a potential avenue for studying spontaneous mutations due to their inheritance pattern.

Purpose of the Study:

  • To investigate the feasibility of detecting spontaneous inactivating somatic mutations using the X-linked XK gene.
  • To establish a method for identifying red blood cells with phenotypes similar to McLeod syndrome.
  • To determine the frequency of such variants in neonatal and adult populations.

Main Methods:

  • Utilized flow cytometry to detect red blood cells exhibiting a specific phenotype.
  • Focused on identifying variants related to the XK gene, known for its role in McLeod syndrome.
  • Analyzed neonatal cord blood and adult blood samples.

Main Results:

  • Phenotypic variants resulting from spontaneous XK gene mutations were detected.
  • Median frequencies were 9 x 10^-6 in neonatal cord blood and 39 x 10^-6 in healthy adults.
  • A statistically significant difference in frequency was observed between neonatal and adult samples (p=0.004).

Conclusions:

  • The study successfully identified a method to detect spontaneous inactivating somatic mutations in the XK gene.
  • The findings suggest that X-linked genes can serve as markers for spontaneous mutations.
  • This approach holds potential for future research into the links between aging, mutation accumulation, and cancer.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...